Repligen expands process analytics portfolio with DRS Daylight Solutions agreement
Repligen Corporation, a life sciences company focused on bioprocessing technology leadership, today announced it has entered into a strategic partnership ...
Repligen Corporation, a life sciences company focused on bioprocessing technology leadership, today announced it has entered into a strategic partnership ...
In a recent study published in the Journal of Antimicrobial Chemotherapy, researchers developed an antibiotic resistance (ABR) awareness scale to...
Read moreSome labs publish new papers every month and get millions in grant money. How do they do it? No, it’s...
Read moreRemotely controlled miniature biological robots — biobots — have many potential applications in medicine, sensing and environmental monitoring. Researchers at...
Read moreTurning a decades-old dogma on its head, new research from scientists at UC San Francisco and Stanford Medicine shows that...
Read more© 2022 Medical Writers News Hubb All rights reserved.
Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.
© 2022 Medical Writers News Hubb All rights reserved.